"This science will enable physicians to prescribe the right medicines at the right dosages and intervals to maximize efficacy and prevent unwanted toxicity. It should be a very exciting next 10 years of research," said D. Wade Clapp, M.D., chairman of the Department of Pediatrics.
"Personalized medicine will make a significant and immediate impact in the care of patients with heart diseases," said Peng-Sheng Chen, M.D., director of the Krannert Institute of Cardiology.
In addition to Flockhart, the institute's leadership will include associate directors Lang Li, Ph.D., associate professor of medical and molecular genetics and associate director of the IU Center for Computational Biology and Bioinformatics; Jamie L. Renbarger, M.D., assistant professor of pediatrics, of medicine and of obstetrics and gynecology; and Bryan Schneider, M.D., assistant professor of medicine and of medical and molecular genetics.
The institute's mission is to conduct research, train new specialists in personalized medicine and promote the translation of scientific discoveries into new more precise therapeutics for patient care.
Training new experts will be supported by the new Brater Scholarship in Personalized Medicine, which will provide funds for research to young physicians in medical fellowship training programs at the school of medicine. The first three fellows to receive Brater scholarships will be selected this summer.
To help move scientific discoveries to patient bedsides, the institute will have a panel of IU scientists who will advise researchers on steps to take to move their research beyond the laboratory stages. The advisory panel, with 21 members initially, will be chaired by Dr. Clapp.
The institute also has an external advisory board with five members:
|Contact: Eric Schoch|
Indiana University School of Medicine